BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

970 related articles for article (PubMed ID: 1384338)

  • 41. [Expression of cytokeratin 19 in the development and progression of oral squamous cell carcinoma].
    Tan D; Li CH; Nie MH
    Shanghai Kou Qiang Yi Xue; 2016 Oct; 25(5):600-603. PubMed ID: 28116435
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Markers of potential malignancy in chronic hyperplastic candidiasis.
    Darling MR; McCord C; Jackson-Boeters L; Copete M
    J Investig Clin Dent; 2012 Aug; 3(3):176-81. PubMed ID: 22489001
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Upregulation of heme oxygenase-1 in oral epithelial dysplasias.
    Lee J; Lee SK; Lee BU; Lee HJ; Cho NP; Yoon JH; Choi HR; Lee SK; Kim EC
    Int J Oral Maxillofac Surg; 2008 Mar; 37(3):287-92. PubMed ID: 18272347
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Proliferating cell nuclear antigen in malignant and pre-malignant lesions of epithelial origin in the oral cavity and the skin: an immunohistochemical study.
    Tsuji T; Shrestha P; Yamada K; Takagi H; Shinozaki F; Sasaki K; Maeda K; Mori M
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(5):377-83. PubMed ID: 1375793
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Immunohistological evaluation of Ki-67, p63, CK19 and p53 expression in oral epithelial dysplasias.
    Takeda T; Sugihara K; Hirayama Y; Hirano M; Tanuma JI; Semba I
    J Oral Pathol Med; 2006 Jul; 35(6):369-75. PubMed ID: 16762018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
    Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
    Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increase in placental glutathione S-transferase in human oral epithelial dysplastic lesions and squamous cell carcinomas.
    Zhang L; Xiao Y; Priddy R
    J Oral Pathol Med; 1994 Feb; 23(2):75-9. PubMed ID: 8164157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Patterns of p53 and Ki-67 protein expression in epithelial dysplasia from the floor of the mouth.
    Kushner J; Bradley G; Jordan RC
    J Pathol; 1997 Dec; 183(4):418-23. PubMed ID: 9496258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Overexpression of p16INK4 is a reliable marker of human papillomavirus-induced oral high-grade squamous dysplasia.
    Cunningham LL; Pagano GM; Li M; Tandon R; Holm SW; White DK; Lele SM
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Jul; 102(1):77-81. PubMed ID: 16831676
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The expression of proliferating cell nuclear antigen (PCNA) and p 53 protein correlate with prognosis of patients with oral squamous cell carcinoma.
    Kurokawa H; Yamashita Y; Takeda S; Miura K; Murata T; Kajiyama M
    Fukuoka Igaku Zasshi; 1999 Jan; 90(1):6-13. PubMed ID: 10087668
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [P53 expression and clinical significance in oral squamous cell carcinoma].
    Long Y; Ling D; Yue W
    Hua Xi Kou Qiang Yi Xue Za Zhi; 1997 May; 15(2):115-6, 122. PubMed ID: 11480024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Second carcinomas in cancers of the mouth cavity, pharynx and larynx. Clinical, histopathologic and cell kinetic findings].
    Esser D; Anke S; Roessner A; Freigang B
    Laryngorhinootologie; 2000 Aug; 79(8):478-82. PubMed ID: 11006912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Usefulness of a fluorescence visualization system for the detection of oral precancerous and early cancerous lesions.
    Ohnishi Y; Fujii T; Ugaki Y; Yasui H; Watanabe M; Dateoka S; Kakudo K
    Oncol Rep; 2016 Jul; 36(1):514-20. PubMed ID: 27121913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biologic characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen.
    Koga Y; Kuwano H; Sugimachi K
    Cancer; 1996 Jan; 77(2):237-44. PubMed ID: 8625229
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of p53 family members and CD44 in oral squamous cell carcinoma (OSCC) in relation to tumorigenesis.
    Bidaud P; Chasle J; Sichel F; Rousseau S; Petit P; Pottier D; Picquenot JM; Louis MY; Lechevrel M
    Histol Histopathol; 2010 Mar; 25(3):331-9. PubMed ID: 20054805
    [TBL] [Abstract][Full Text] [Related]  

  • 57. p53 and MDM2 protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.
    Ambrosch P; Ruschenburg I
    Anticancer Res; 2000; 20(5A):3151-5. PubMed ID: 11062736
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Expression of integrin-linked kinase in oral leukoplakia and early invasive carcinoma].
    Guo ZL; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2010 Mar; 45(3):163-7. PubMed ID: 20450685
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma.
    Rani V; McCullough M; Chandu A
    J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Apoptosis-associated proteins and the development of oral squamous cell carcinoma.
    Schoelch ML; Le QT; Silverman S; McMillan A; Dekker NP; Fu KK; Ziober BL; Regezi JA
    Oral Oncol; 1999 Jan; 35(1):77-85. PubMed ID: 10211314
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 49.